Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Letian Huang"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract This systematic review and network meta-analysis evaluates first-line treatment options for patients with EGFR-mutant non-small cell lung cancer (NSCLC) and brain metastases. We analyzed 24 randomized controlled trials (RCTs) involving 2,682
Externí odkaz:
https://doaj.org/article/8ebe442c00564a6bbb358712a3a844c2
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Third-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have emerged as the mainstay of treatment for advanced EGFR-mutant advanced non-small cell lung cancer (NSCLC), effectively overcoming the problems of acquired t
Externí odkaz:
https://doaj.org/article/d029cb9ca47d49f8838888ee246e6353
Autor:
Weilong Chen, Xiaohang Wang, Ye Sun, Qiao Hu, Letian Huang, Yingtao Jiang, Amit Kumar Singh, Terrence Mak, Mei Yang
Publikováno v:
IEEE Access, Vol 9, Pp 149399-149422 (2021)
The academia and industry have been pursuing network-on-chip (NoC) related research since two decades ago when there was an urgency to respond to the scaling and technological challenges imposed on intra-chip communication in SoC designs. Like any ot
Externí odkaz:
https://doaj.org/article/337ea6ef0b774e589d637c1ca5c022ea
Autor:
Jun Song, Xiaofang Yi, Ruolin Gao, Li Sun, Zhixuan Wu, Shuling Zhang, Letian Huang, Chengbo Han, Jietao Ma
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
In recent years, various breakthroughs have been made in tumor immunotherapy that have contributed to prolonging the survival of tumor patients. However, only a subset of patients respond to immunotherapy, which limits its use. One reason for this is
Externí odkaz:
https://doaj.org/article/137671b83ecc4e508f42a07a1b8e7757
Autor:
Yijia Guo, Jun Song, Yanru Wang, Letian Huang, Li Sun, Jianzhu Zhao, Shuling Zhang, Wei Jing, Jietao Ma, Chengbo Han
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) greatly improve the survival and quality of life of non-small cell lung cancer (NSCLC) patients with EGFR mutations. However, many patients exhibit de novo or primary/early resis
Externí odkaz:
https://doaj.org/article/240cde220a2849c092135b1f1b7cc208
Autor:
Xiaohang Wang, Hengli Huang, Ruolin Chen, Yingtao Jiang, Amit Kumar Singh, Mei Yang, Letian Huang
Publikováno v:
IEEE Transactions on Computers. 72:971-983
Publikováno v:
IEEE Transactions on Computers. 72:494-500
Autor:
Chixiao Chen, Jieming Yin, Yarui Peng, Maurizio Palesi, Wenxu Cao, Letian Huang, Amit Kumar Singh, Haocong Zhi, Xiaohang Wang
Publikováno v:
IEEE Design & Test. 39:99-109
Autor:
Jiaen Xu, Xiaohang Wang, Yingtao Jiang, Amit Kumar Singh, Chongyan Gu, Letian Huang, Mei Yang, Shunbin Li
Publikováno v:
IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 41:4313-4324
Publikováno v:
IEEE Transactions on Computer-Aided Design of Integrated Circuits and Systems. 41:4064-4075